“…Finally, we discuss how changes in DNA methylation, especially in glioblastomas bearing mutations in the Isocitrate Dehydrogenase (IDH) 1 and 2 genes, can be exploited as targets for tailoring therapy.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…However, targeted therapy aimed at tumors with fusion mutations of the fibroblast growth factor receptor (FGFR), isocitrate dehydrogenase (IDH) 1 and 2, the genes encoding the B-Raf protein (BRAF), breast cancer (BRCA1/2), epidermal growth factor receptor 2 (HER2), and the neurotrophic receptor tyrosine kinase gene (NTRK), is gradually changing the paradigm in the treatment of this disease. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Giant cell glioblastoma is a rare tumor entity of IDH-wildtype glioblastoma. It is usually found in the pediatric population. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Next-generation sequencing identified isocitrate dehydrogenase 2 (IDH2) (p.R172S, c.516G>T), TERT (c.-146C>T), and TP53 (c.559+1G>A) mutations. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The proposed FL scheme has obtained good performance on the test sets (85.46%, 75.56%) for IDH subtypes and (89.28%, 90.72%) for glioma LGG/HGG all averaged on five runs. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RRD3 (Olig2-Cre(+)/Msh2(LoxP/LoxP)/Trp53(LoxP/LoxP)/LSL-Idh1(R132H/+)): brain tumors occur later and are hemispheric. …”
Enlace del recurso
Enlace del recurso

“…A subgroup analysis of isocitrate dehydrogenase (IDH) mutant tumors indicated a superior performance of PWI to [(18)F]FET PET (AUC = 0.8/< 0.62, p < 0.01/≥ 0.3). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CNVs of LANCL2 or EGFR were significantly correlated with IDH1/2 mutation but not MGMT promoter methylation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In this article, we will review (1) the emerging molecular MRD markers (such as non-DTA mutations, IDH1/2, and FLT3-ITD); (2) the impact of novel therapeutics on MRD endpoints; and (3) how MRD might be used as a predictive biomarker to guide therapy in AML beyond its prognostic role, which is the focus of two large collaborative trials: AMLM26 INTERCEPT (ACTRN12621000439842) and MyeloMATCH (NCT05564390).…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In this study, we reveal that polypeptide N-acetylgalactosaminyltransferase 5 (GALNT2) expression level was elevated in GBM, IDH1 wildtype glioma, and GBM stem cells (GSCs). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Agents acting on tumor-specific oncogenes in BTC may target fibroblast growth factor receptor 2 (FGFR2), isocitrate dehydrogenase (IDH), B-raf kinase (BRAF), and human epidermal growth factor receptor 2 (HER-2). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In addition, the present study demonstrated that the mRNA and protein expressions of SIRT5, IDH2, MDH2 and LDHC, associated with sperm quality parameters, are downregulated after cryopreservation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Verteporfin and 5-ALA are used for visualizing malignant tissue components in different body tumors and as photodynamic therapy in treating isocitrate dehydrogenase (IDH) wild-type glioblastoma (GBM). Additionally, verteporfin interferes with Yes-associated protein 1 (YAP)/Transcriptional coactivator with PDZ-binding motif - TEA domain (TAZ-TEAD) pathway, thus inhibiting the downstream effect of these oncogenes and reducing the malignant properties of GBM. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We explored this in 10 AML patients with NPM1 and IDH2 mutations undergoing initial chemotherapy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In order to get a new opinion about the relationships within the family, we undertook a molecular study of the family based on sequences from five genes, mitochondrial COI and the four nuclear genes CAD, EF-1α, IDH and POL. RESULTS: The resulting phylogenetic hypotheses are more or less congruent with the morphologically based classification, with most genera and tribes recovered as monophyletic, but with some major differences. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Among these alterations have been mutations in genes, such as IDH1/2, TET2, DNMT3A, and EZH2, which appear to affect DNA and/or histone lysine methylation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…In 2 patients, both KRAS and DNMT3A were detected simultaneously. A somatic mutation in IDH2 was detected in these 2 patients. One of the patients had an additional mutation in FLT3, while the other patient had an NPM1 mutation. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Novel genome scanning technologies were useful in the identification of recurrent molecular mutations in other genes including MPL, TET2, IDH1/2, DNMT3A, SH3B2 (LNK) and CBL in MF pointing out that other pathways might be important in addition to the JAK/STAT pathway. …”
Enlace del recurso
Enlace del recurso

“…Examples of our findings include cis relationships between copy number alteration, DNA methylation and expression of genes, a new hierarchy of mutations and recurrent copy number alterations, loss-of-heterozygosity of well-known tumor suppressors, and the hypermethylation phenotype associated with IDH1 mutations in GBM. The Boolean implication results used in the paper can be accessed at http://crookneck.stanford.edu/microarray/TCGANetworks/.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The proportion of the classical subtype in recurrent ones (22%) was lower than that in primary glioblastoma (36%). The frequency of IDH1 mutations in recurrent glioblastomas was nearly twice that in primary glioblastomas. …”
Enlace del recurso
Enlace del recurso